OPEN PROTOCOLS
Click on the title to be taken to the NCI web page describing the study.

Protocol	Protocol Title
AMC-045	Phase II Trial Of Combined Modality Therapy Plus Cetuximab in HIV-Associated Anal Carcinoma
AMC-046	A Phase II Trial of Cidofovir in HIV-Infected Patients With High-Grade Perianal Dysplasia
AMC-047	Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma
AMC-048	Prospective Phase II Study Of A High Dose, Short Course Regimen (R-CODOX-M/IVAC) Including CNS Penetration And Intensive IT Prophylaxis In HIV-Associated Burkitt’s And Burkitt’s-Like Lymphoma
AMC-050	Pilot Study of Liposomal Daunorubicin Citrate in Patients With HIV-Related Kaposi's Sarcoma
AMC-051	Pilot Study Of Rapamycin In Patients With HIV-Associated Kaposi's Sarcoma
AMC-052	Single-Arm, Open-Label Trial Of The Safety And Immunogenicity Of A Quadrivalent Human Papillomavirus Vaccine In HIV-1-Infected Men
AMC-053	Safety and Efficacy Pilot Trial of the Anti-Viral and Anti-Tumor Activity of Velcade Combined with (R)ICE in Subjects with EBV and/or HHV-8 positive Relapsed/Refractory AIDS-Associated Non-Hodgkin’s Lymphoma
AMC-058	A Companion Protocol To Evaluate Anogenital Human Papillomavirus (HPV) Infection And Anogenital Squamous Intraepithelial Lesions (ASIL) In Patients Participating In AMC Clinical Trials
AMC-059	Phase I/II Trial of Anti-VEGF Small Molecule PTC299 in Patients With HIV-Related Kaposi's Sarcoma